Astellas Study Results Available for ASP0367 (MA-0211) in Pediatric Male Patients with Duchenne Muscular Dystrophy

November 16, 2023

On November 15, 2023, Astellas Pharma shared a community letter with information on obtaining results for ASP0367 (MA-0211) in Pediatric Male patients with Duchenne muscular dystrophy.

Astellas’ Community Letter can be found by clicking here.

Astellas’ clinical trial study details can be found on their website.

Accessible Vehicle Fund Applications Open